Shrinidhi Nathany on Simulating Cells and Why It is a Game Changer
Shrinidhi Nathany, Consultant Molecular Hematology and Oncology at Fortis Memorial, posted on LinkedIn:
“Thought provoking read
What if we could simulate the cell?
For years, the idea of a virtual cell sounded unrealistic. Cells are complex, dynamic, and shaped by countless molecular interactions. Today, that view is changing.
With advances in single cell biology, spatial omics, perturbation data, and AI, scientists are beginning to build models that can predict how cells respond to genes, drugs, and environmental signals. These are not perfect replicas, but practical, predictive systems.
Virtual cells could transform drug discovery and precision medicine by allowing millions of experiments to be run computationally, guiding lab work, improving patient selection, and helping match the right therapy to the right patient.
The challenges are real, especially data scale and quality. But the direction is clear.
Making the cell predictable would redefine how we study disease and design treatments. The virtual cell is no longer science fiction. It is becoming a new tool for biology.”
Title: Inside the Virtual Cell: New Depths for Precision Medicine
Authors: Clara Rodriguez Fernandez
Read full article here.
Stay informed with Hemostasis Today.
-
Dec 17, 2025, 06:28Wolfgang Miesbach on Linus Völker’s Presentation of Caplacizumab as Frontline Therapy for iTTP
-
Dec 17, 2025, 06:11Lisa Murphy Thanks Stroke Foundation Team for An Impactful, Rewarding and Incredible Year
-
Dec 17, 2025, 06:05Emmanuel J Favaloro Shares A Study on AI and Machine Learning in Thrombosis and Hemostasis
-
Dec 17, 2025, 05:54Michael Bruckman: Fantastic to See Platelet-Inspired Nanoparticles Gaining Attention!
-
Dec 17, 2025, 04:00Peter Verhamme on Genetic Predisposition to Thromboembolism and COVID
-
Dec 16, 2025, 23:14Shrinidhi Nathany: MRD in AML – From a Test to a Treatment Decision
-
Dec 16, 2025, 23:04Jim Hoffman: Timely Extracorporeal NET Removal Therapy Should Be Tried on High-Risk Patients
-
Dec 16, 2025, 22:16Wolfgang Miesbach – Targeting VEGF to Stop GI Bleeding: Systemic Bevacizumab
-
Dec 16, 2025, 17:14Piotr Czempik Honored for His Work on Cost Reduction in Blood Transfusions